FIELD: biotechnology.
SUBSTANCE: method involves isolation of a population of stromal stem cells based on syndecan-2 expression from a mixed population of adult mammalian stromal cells.
EFFECT: invention allows to obtain a population of stromal stem cells.
8 cl, 16 dwg, 14 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CELLS DERIVED FROM CARDIAC TISSUE | 2010 |
|
RU2662675C1 |
| METHOD OF CULTIVATION, FIBROBLASTS, METHOD OF CELL SEPARATION | 1991 |
|
RU2164240C2 |
| HUMAN UTERINE CERVICAL STEM CELL POPULATION AND USES THEREOF | 2014 |
|
RU2679500C2 |
| METHODS OF RE-CELLULARIZATION OF TISSUE OR ORGAN FOR IMPROVEMENT OF TRANSPLANT ENGRAFTMENT | 2011 |
|
RU2611361C2 |
| CELLS DERIVED FROM CARDIAL TISSUE | 2010 |
|
RU2642282C1 |
| AMNIOTIC ADHESIVE CELLS | 2009 |
|
RU2562154C2 |
| PLACENTAL TISSUE CELLS GROWN IN SUBSTRATE-ATTACHED CULTURE AND USING THEM IN TREATING | 2009 |
|
RU2539786C2 |
| CELLS BEING DERIVATIVES OF CARDIAC TISSUE | 2010 |
|
RU2583287C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT NEOPLASM | 2018 |
|
RU2730984C1 |
| METHOD OF ACCELERATED ACQUIRING OF MESENCHYMAL STEM CELLS (MSC) CULTURE OF MAMMALS, EXCEPT HUMAN, WITH LOW HETEROGENEITY AND HIGH VIABILITY | 2007 |
|
RU2331670C1 |
